Commitment COM-161
Post-approval commitment for FDA-2024-0061. Category: Pharmacovigilance. Priority: high.
Commitment ID
COM-161
Application
Authority
Food and Drug Administration
Category
Pharmacovigilance
Priority
high
Status
In Progress
Due Date
2025-03-15
Completed At
—
Owner
Priya Sharma
Created
2023-06-09
Description
Implement Risk Minimisation Measures (RMM) per REMS requirements
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.